Year in Review: Updates in Immunotherapy-Based Treatment Approaches for NSCLC

Edgardo Santos, MD, FACP, FCCP, clinical affiliate associate professor, Florida Atlantic University; Vice-President, Florida Society of Clinical Oncology, discusses key advancements in immunotherapy-based treatment approaches for NSCLC in 2023.

EP. 1: Immunotherapy-Based Strategies for NSCLC in the Neoadjuvant/Perioperative Setting

December 15th 2023

Dr. Eduardo Santos, MD, FACP, FCCP, provides and overview of immunotherapy-based treatment strategies for NSCLC in the neoadjuvant and perioperative setting.

EP. 2: Advances in Neoadjuvant Immunotherapy for NSCLC: Conference Highlights 2023

December 15th 2023

Dr. Eduardo Santos, MD, FACP, FCCP, highlights advancements in neoadjuvant immunotherapy for NSCLC presented during key conferences in 2023, underscoring pivotal findings and the potential transformation of treatment approaches.

EP. 3: Updates in Adjuvant Immunotherapy for NSCLC: Conference Highlights 2023

December 22nd 2023

Dr. Eduardo Santos, MD, FACP, FCCP, examines immunotherapy-based treatment approaches for NSCLC in the adjuvant setting, highlighting updates from KEYNOTE-091.

EP. 4: Immunotherapy-Based Treatment Strategies in Advanced NSCLC

December 22nd 2023

Eduardo Santos, MD, FACP, FCCP, provides an overview of immunotherapy-based treatment strategies for advanced NSCLC, outlining key factors influencing treatment selection.

EP. 5: EMPOWER-Lung3: Evaluating Cemiplimab Plus Chemotherapy in Advanced NSCLC

December 29th 2023

Eduardo Santos, MD, FACP, FCCP, highlights key takeaways from the latest EMPOWER-LUNG03 data and discusses the impact of these findings on the treatment setting.

EP. 6: Advancements in Squamous NSCLC Treatment: Subgroup Analysis from EMPOWER-Lung Trials

December 29th 2023

Eduardo Santos, MD, FACP, FCCP, delves into advancements in the treatment of squamous NSCLC, emphasizing crucial insights from the EMPOWER-Lung01 and EMPOWER-Lung03 subgroup analysis.

EP. 7: Advances in Dual Immunotherapy Approaches for NSCLC: Data Highlights 2023

January 5th 2024

Eduardo Santos, MD, FACP, FCCP, discusses recent advances in dual immunotherapy approaches for NSCLC, highlighting data from the CheckMate 9LA study.

EP. 8: NSCLC 2023 Data Updates: Shaping the Future Treatment Landscape

January 5th 2024

Eduardo Santos, MD, FACP, FCCP, highlights the most impactful and treatment-changing data updates for NSCLC in 2023, and provides perspective on how these finding may shape the future direction of care.